Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France-Reference-Cited by-同舟云学术

Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France

Published:2009-07-07 Issue:5 Volume:50 Page:1351-1359
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Deuffic-Burban Sylvie,Babany Gérard,Lonjon-Domanec Isabelle,Deltenre Pierre,Canva-Delcambre Valérie,Dharancy Sébastien,Louvet Alexandre,Roudot-Thoraval Françoise,Mathurin Philippe

Publisher

Wiley

Subject

Hepatology

Reference39 articles.

1. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C;Piton;HEPATOLOGY,1998

2. Treatment of patients with chronic hepatitis C and normal ALT levels;Tassopoulos;J Hepatol,1999

3. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features;Shakil;Ann Intern Med,1995

4. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA;Martinot-Peignoux;HEPATOLOGY,2001

5. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels;Persico;Gastroenterology,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Model to Identify Heavy Drinkers at High Risk for Liver Disease Progression;Clinical Gastroenterology and Hepatology;2020-09

2. Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels;PLOS ONE;2016-03-11

3. Loss to follow-up in anti-HCV-positive patients in a Brazilian regional outpatient clinic;Brazilian Journal of Medical and Biological Research;2016

4. Patient-important benefits of clearing the hepatitis C virus through treatment: A simulation model;Journal of Hepatology;2014-06

5. Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: A modelling approach;Digestive and Liver Disease;2014-02